This is a great pill, I have had no side effects and find I've been more regular since I started taking glp1
The body's metabolic adaptations to weight lossincluding decreased energy expenditure, increased hunger hormones, and reduced satiety signalspersist long after weight reduction, making weight maintenance challenging without continued intervention
Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate
Brenner, D
Smith MH
Either vehicle, exendin 939, exendin 2029, or BCTC was first injected via the intraplantar route, and 30 min later, an additional injection of exendin 939, exendin 2029, or BCTC in combination with CAP was administered
